Literature DB >> 1359226

PET with fluorine-18 deoxyglucose for pancreatic disease.

P Klever, R Bares, J Fass, U Büll, V Schumpelick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359226     DOI: 10.1016/0140-6736(92)93183-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Utility of fusion CT-PET in the diagnosis of small pancreatic carcinoma.

Authors:  Brian Kim-Poh Goh; Yu-Meng Tan; Yaw-Fui Alexander Chung
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 2.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 3.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

4.  Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem.

Authors:  T Kato; H Fukatsu; K Ito; M Tadokoro; T Ota; M Ikeda; T Isomura; S Ito; M Nishino; T Ishigaki
Journal:  Eur J Nucl Med       Date:  1995-01

5.  Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  H Friess; J Langhans; M Ebert; H G Beger; J Stollfuss; S N Reske; M W Büchler
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

6.  CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer.

Authors:  Mark D Girgis; Tove Olafsen; Vania Kenanova; Katelyn E McCabe; Anna M Wu; James S Tomlinson
Journal:  Int J Mol Imaging       Date:  2011-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.